Literature DB >> 11675130

Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas.

L Glukhova1, E Angevin, C Lavialle, B Cadot, M J Terrier-Lacombe, B Perbal, A Bernheim, A F Goguel.   

Abstract

A series of 13 sporadic renal cell carcinomas was analyzed for the specific chromosome rearrangements after serial xenografting into immunodeficient mice. Seven tumors displayed genetic traits of the conventional subtype and 5 showed genetic features of the papillary subtype. In all the xenografted conventional tumors, we observed loss of 3p, as well as loss of the 9p21 region and of the long arm of chromosome 14, both considered as markers of a poor prognosis. In the xenografted papillary tumors, a duplication of chromosome arm 8q was observed concomitant with the duplication of the 7q31 region. The association of the 7q31 and 8q22 approximately qter duplicated regions was also observed for one conventional tumor. The latency of tumor take was found to be reduced and the median time to passage statistically shorter for all tumors which presented the associated duplication of the 7q31 and 8q22 approximately qter regions. The proto-oncogene NOV (nephroblastoma overexpressed gene) maps to 8q24.1 and is overexpressed in some Wilms tumors. It could be an interesting candidate gene, since its level of expression and release in the culture medium was found to be increased in all of the fast growing tumors analyzed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675130     DOI: 10.1016/s0165-4608(01)00477-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  23 in total

1.  CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

Authors:  Véronique Ouellet; Kerstin Tiedemann; Anna Mourskaia; Jenna E Fong; Danh Tran-Thanh; Eitan Amir; Mark Clemons; Bernard Perbal; Svetlana V Komarova; Peter M Siegel
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Authors:  Guo-Wei Zuo; Christopher D Kohls; Bai-Cheng He; Liang Chen; Wenli Zhang; Qiong Shi; Bing-Qiang Zhang; Quan Kang; Jinyong Luo; Xiaoji Luo; Eric R Wagner; Stephanie H Kim; Farbod Restegar; Rex C Haydon; Zhong-Liang Deng; Hue H Luu; Tong-Chuan He; Qing Luo
Journal:  Histol Histopathol       Date:  2010-06       Impact factor: 2.303

3.  CCN3: Doctor Jekyll and Mister Hyde.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-12       Impact factor: 5.782

4.  Flaws in the peer-reviewing process : a critical look at a recent paper studying the role of CCN3 in renal cell carcinoma.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2012-08-03       Impact factor: 5.782

5.  Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV).

Authors:  N Gupta; H Wang; T L McLeod; C C Naus; S Kyurkchiev; S Advani; J Yu; B Perbal; R R Weichselbaum
Journal:  Mol Pathol       Date:  2001-10

6.  CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser; Darryl R Peterson
Journal:  J Cell Commun Signal       Date:  2010-02-09       Impact factor: 5.782

7.  A role for CCN3 (NOV) in calcium signalling.

Authors:  C L Li; V Martinez; B He; A Lombet; B Perbal
Journal:  Mol Pathol       Date:  2002-08

8.  CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Darryl R Peterson; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

9.  CCN family of proteins: critical modulators of the tumor cell microenvironment.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

10.  Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

Authors:  M Fukunaga-Kalabis; G Martinez; S M Telson; Z-J Liu; K Balint; I Juhasz; D E Elder; B Perbal; M Herlyn
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.